Navigation Links
University of Colorado joins forces with major research affiliate

AURORA (July 22, 2010) A major research company affiliated with the University of Colorado with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.

CPC, formally known as the Colorado Prevention Center, officially moved into the University Physicians Incorporated building across the street from the campus on Friday.

It is the first tenant in the new building, symbolic of the emphasis researchers have placed on stem cells and their far reaching implications for the future of health care.

The company will partner with the CU School of Medicine's Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology which is expected to attract research money from around the world and bring new jobs to the area.

William Hiatt, MD, president of CPC and professor of medicine at the University of Colorado, said the move will solidify "our critical relationship" with the Stem Cell Center.

"With the collaboration of the Stem Cell Center's scientists and our ability to manage future clinical trials and the School of Medicine's commitment to this combined program, our ability to advance new therapies is tremendous," he said.

CPC, the parent company of CPC Clinical Research and CPC Community Health, is a non-profit created by the Department of Medicine that has been managing clinical trials for more than 20 years. Scientists and administrators hope the partnership will speed up the transition from work in the lab to work with actual patients.

Dennis Roop, PhD, director of the Center for Regenerative Medicine and Stem Cell Biology, said the alliance could produce major breakthroughs in cancer research, treating skin diseases, regrowing damaged veins and arteries and creating a steady supply of clean, human blood.

"We could take a biopsy of a damaged cornea, grow the stem cells, transplant them to the patient and restore vision," he said. "Currently we don't have a program like that in the U.S., but this has created an opportunity to do it here."

Lilly Marks, vice-president for health affairs at the University of Colorado and executive vice-chancellor of the University of Colorado's Anschutz Medical Campus, said the move will further enhance the scope and reach of the campus.

"We want to make this the epicenter of health care throughout the Rocky Mountains and beyond," Marks said. "The stem cell research and trials that go on here will impact the entire world." Colorado State Sen. Morgan Carroll of Aurora was on hand at Friday's press conference to lend her support. "This partnership will attract research grants and new business," she said. "And it will also save lives."


Contact: David Kelly
University of Colorado Denver

Related medicine news :

1. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
2. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
3. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Smithsonian Institution, Arizona State University announce education and research partnership
6. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
7. Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan
8. Arizona State Universitys Decision Theater offers balance to an off-kilter world
9. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
10. Herzing University Online Launches Master and Bachelor of Science Degrees in Nursing
11. Nurtur Acquires ActivHealth and Wellness by Choice; Gains Exclusive Partnership with Duke University Center for Living
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... December 01, 2015 , ... TCS Healthcare Technologies (TCS), ... population health arenas, is pleased to announce that VIP Care Services, a Caprock ... implemented the ACUITY Complete Care™ Management to back their collaborative catastrophic case management ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , a leader ... leadership since 2008. Gary Bruce, President of PartnerTech North America, currently serves as ... significant amount of time in Sweden since joining PartnerTech based in Malmo, Sweden. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash ... Modern Man for 2015. , Angeleno Magazine is a division of Modern ... in 1994, Modern Luxury includes more than 50 magazine titles across 15 major ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 During ... in San Francisco, CA , ... to the coronary marketplace. During a satellite symposium, ... Stent Design to Minimize Restenosis", a renowned physician ... available Medinol NIRxcell™ CoCr Coronary Stent System and ...
(Date:12/1/2015)... DUBLIN , Dec. 01, 2015 ... addition of the "Veterinary Equipment and Disposables ... to 2020" report to their offering. ... of the "Veterinary Equipment and Disposables Market ... 2020" report to their offering. --> ...
(Date:12/1/2015)... , Dec. 1, 2015   MabVax Therapeutics Holdings, ... company, announces it has filed an Investigational New Drug ... (FDA) for the Company,s lead fully human antibody product ... acceptance, MabVax plans to initiate the Phase I clinical ... --> The planned Phase I trial ...
Breaking Medicine Technology: